Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia

Hypoxia-inducible factor prolyl hydroxylase inhibitors stabilize levels of hypoxia-inducible factor that upregulate transcription of multiple genes associated with the response to hypoxia, including production of erythropoietin. We conducted two phase 2a studies to explore the relationship between t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Soc Nephrol
Egile Nagusiak: Holdstock, Louis, Meadowcroft, Amy M., Maier, Rayma, Johnson, Brendan M., Jones, Delyth, Rastogi, Anjay, Zeig, Steven, Lepore, John J., Cobitz, Alexander R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2016
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4814173/
https://ncbi.nlm.nih.gov/pubmed/26494831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014111139
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak